
Alex T. Devito
Examiner (ID: 13221, Phone: (571)270-7551 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2856, 2855 |
| Total Applications | 868 |
| Issued Applications | 597 |
| Pending Applications | 73 |
| Abandoned Applications | 223 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5847744
[patent_doc_number] => 20060123496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Animal models'
[patent_app_type] => utility
[patent_app_number] => 10/521319
[patent_app_country] => US
[patent_app_date] => 2003-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10568
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20060123496.pdf
[firstpage_image] =>[orig_patent_app_number] => 10521319
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/521319 | Animal models | Jul 16, 2003 | Abandoned |
Array
(
[id] => 5778698
[patent_doc_number] => 20060107338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Hepatic cirrhosis model animal and method of constructing the same'
[patent_app_type] => utility
[patent_app_number] => 10/521411
[patent_app_country] => US
[patent_app_date] => 2003-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4396
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20060107338.pdf
[firstpage_image] =>[orig_patent_app_number] => 10521411
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/521411 | Hepatic cirrhosis model animal and method of constructing the same | Jul 13, 2003 | Abandoned |
Array
(
[id] => 5842168
[patent_doc_number] => 20060121008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Primarily cultured adipocytes for gene therapy'
[patent_app_type] => utility
[patent_app_number] => 10/518472
[patent_app_country] => US
[patent_app_date] => 2003-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 13183
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121008.pdf
[firstpage_image] =>[orig_patent_app_number] => 10518472
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/518472 | Primary cultured adipocytes for gene therapy | Jun 17, 2003 | Issued |
Array
(
[id] => 4567860
[patent_doc_number] => 07858367
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-28
[patent_title] => 'Viral vectors and methods for producing and using the same'
[patent_app_type] => utility
[patent_app_number] => 10/511980
[patent_app_country] => US
[patent_app_date] => 2003-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 19508
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/858/07858367.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511980
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511980 | Viral vectors and methods for producing and using the same | Apr 29, 2003 | Issued |
Array
(
[id] => 5709986
[patent_doc_number] => 20060051331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Optimization of transgene expression in mammalian cells'
[patent_app_type] => utility
[patent_app_number] => 10/511343
[patent_app_country] => US
[patent_app_date] => 2003-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9762
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051331.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511343
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511343 | Optimization of transgene expression in mammalian cells | Apr 28, 2003 | Abandoned |
Array
(
[id] => 6678904
[patent_doc_number] => 20030229045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'CFTR gene regulator'
[patent_app_type] => new
[patent_app_number] => 10/407177
[patent_app_country] => US
[patent_app_date] => 2003-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4064
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20030229045.pdf
[firstpage_image] =>[orig_patent_app_number] => 10407177
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/407177 | CFTR gene regulator | Apr 6, 2003 | Abandoned |
Array
(
[id] => 7316369
[patent_doc_number] => 20040034878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Compositions and methods for mediating cell cycle progression'
[patent_app_type] => new
[patent_app_number] => 10/408157
[patent_app_country] => US
[patent_app_date] => 2003-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 25385
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20040034878.pdf
[firstpage_image] =>[orig_patent_app_number] => 10408157
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/408157 | p27-deficient mouse exhibiting tissue hypertrophy | Apr 2, 2003 | Issued |
Array
(
[id] => 6678903
[patent_doc_number] => 20030229044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Use of statins and other immunomodulatory agents in the treatment of autoimmune disease'
[patent_app_type] => new
[patent_app_number] => 10/404679
[patent_app_country] => US
[patent_app_date] => 2003-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 27394
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20030229044.pdf
[firstpage_image] =>[orig_patent_app_number] => 10404679
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/404679 | Use of statins and other immunomodulatory agents in the treatment of autoimmune disease | Mar 30, 2003 | Abandoned |
Array
(
[id] => 6663676
[patent_doc_number] => 20030203002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Mineralization and cellular patterning on biomaterial surfaces'
[patent_app_type] => new
[patent_app_number] => 10/403250
[patent_app_country] => US
[patent_app_date] => 2003-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17313
[patent_no_of_claims] => 95
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20030203002.pdf
[firstpage_image] =>[orig_patent_app_number] => 10403250
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/403250 | Mineralization and cellular patterning on biomaterial surfaces | Mar 30, 2003 | Abandoned |
Array
(
[id] => 6809533
[patent_doc_number] => 20030199472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Adenovirus-mediated therapy for uterine fibroids'
[patent_app_type] => new
[patent_app_number] => 10/392274
[patent_app_country] => US
[patent_app_date] => 2003-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 24683
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20030199472.pdf
[firstpage_image] =>[orig_patent_app_number] => 10392274
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/392274 | Adenovirus-mediated therapy for uterine fibroids | Mar 18, 2003 | Abandoned |
Array
(
[id] => 7145390
[patent_doc_number] => 20050119206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis'
[patent_app_type] => utility
[patent_app_number] => 10/507617
[patent_app_country] => US
[patent_app_date] => 2003-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 57
[patent_no_of_words] => 22190
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10507617
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/507617 | Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis | Mar 13, 2003 | Abandoned |
Array
(
[id] => 6914119
[patent_doc_number] => 20050177877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Process for producing physiologically active protein using genetically modified silkworm'
[patent_app_type] => utility
[patent_app_number] => 10/506327
[patent_app_country] => US
[patent_app_date] => 2003-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 15682
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20050177877.pdf
[firstpage_image] =>[orig_patent_app_number] => 10506327
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/506327 | Process for producing physiologically active protein using genetically modified silkworm | Mar 5, 2003 | Issued |
Array
(
[id] => 7224708
[patent_doc_number] => 20040072775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Enhancing the sensitivity of tumor cells to therapies'
[patent_app_type] => new
[patent_app_number] => 10/374665
[patent_app_country] => US
[patent_app_date] => 2003-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11307
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072775.pdf
[firstpage_image] =>[orig_patent_app_number] => 10374665
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/374665 | Enhancing the sensitivity of tumor cells to therapies | Feb 24, 2003 | Abandoned |
Array
(
[id] => 6958570
[patent_doc_number] => 20050214940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Pure populations of astrocyte restricted precursor cells and methods for isolation and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/502224
[patent_app_country] => US
[patent_app_date] => 2003-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5511
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214940.pdf
[firstpage_image] =>[orig_patent_app_number] => 10502224
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/502224 | Pure populations of astrocyte restricted precursor cells and methods for isolation and use thereof | Jan 22, 2003 | Abandoned |
Array
(
[id] => 7075258
[patent_doc_number] => 20050148526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Methods of obtaining isoform specific expression in mammalian cells'
[patent_app_type] => utility
[patent_app_number] => 10/502235
[patent_app_country] => US
[patent_app_date] => 2003-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7999
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148526.pdf
[firstpage_image] =>[orig_patent_app_number] => 10502235
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/502235 | Methods of obtaining isoform specific expression in mammalian cells | Jan 21, 2003 | Abandoned |
Array
(
[id] => 865147
[patent_doc_number] => 07368546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-06
[patent_title] => 'Human SAA3 nucleic acid molecule, protein, and methods of use for same'
[patent_app_type] => utility
[patent_app_number] => 10/348304
[patent_app_country] => US
[patent_app_date] => 2003-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 3
[patent_no_of_words] => 19316
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/368/07368546.pdf
[firstpage_image] =>[orig_patent_app_number] => 10348304
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/348304 | Human SAA3 nucleic acid molecule, protein, and methods of use for same | Jan 20, 2003 | Issued |
Array
(
[id] => 73753
[patent_doc_number] => 07749735
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-06
[patent_title] => 'IFNAR2 mutants, their production and use'
[patent_app_type] => utility
[patent_app_number] => 10/500521
[patent_app_country] => US
[patent_app_date] => 2002-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9664
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/749/07749735.pdf
[firstpage_image] =>[orig_patent_app_number] => 10500521
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/500521 | IFNAR2 mutants, their production and use | Dec 30, 2002 | Issued |
Array
(
[id] => 7176229
[patent_doc_number] => 20050123551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Compositions and methods relating to endometrial specific genes and proteins'
[patent_app_type] => utility
[patent_app_number] => 10/499353
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75591
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123551.pdf
[firstpage_image] =>[orig_patent_app_number] => 10499353
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/499353 | Compositions and methods relating to endometrial specific genes and proteins | Dec 19, 2002 | Abandoned |
Array
(
[id] => 7208804
[patent_doc_number] => 20050043530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Seminal vesicle tissue-specific promoters and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/499406
[patent_app_country] => US
[patent_app_date] => 2002-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9851
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043530.pdf
[firstpage_image] =>[orig_patent_app_number] => 10499406
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/499406 | Seminal vesicle tissue-specific promoters and uses thereof | Dec 18, 2002 | Abandoned |
Array
(
[id] => 6659090
[patent_doc_number] => 20030134314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Methods and compositions for treating hematological disorders using 252, 304, 1980, 14717, 9941, 19310 and 17832'
[patent_app_type] => new
[patent_app_number] => 10/320351
[patent_app_country] => US
[patent_app_date] => 2002-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34226
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20030134314.pdf
[firstpage_image] =>[orig_patent_app_number] => 10320351
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/320351 | Methods and compositions for treating hematological disorders using 252, 304, 1980, 14717, 9941, 19310 and 17832 | Dec 15, 2002 | Abandoned |